On September 26, 2018, the EU General Court (the Court) upheld the European Commission’s refusal to reinvestigate GlaxoSmithKline SA’s (GSK) Spanish “dual-pricing” distribution arrangements, 20 years after the alleged conduct...more
10/5/2018
/ Anti-Competitive ,
Competition Authorities ,
Dual-Pricing ,
EU ,
European Commission ,
General Court of the European Union (GCEU) ,
GlaxoSmithKline ,
Pharmaceutical Industry ,
Sales & Distribution Agreements ,
Spain ,
Treaty on the Functioning of the European Union (TFEU)